Results 231 to 240 of about 22,949 (256)

Post‐marketing surveillance of drugs

Medical Journal of Australia, 1991
H Peter Roeser, Alain P Rohan
openaire   +2 more sources

Post-marketing device safety surveillance

Contemporary Clinical Trials, 2011
Venkatesan D, Vidi, Michael E, Matheny, Frederic S, Resnic   +2 more
openaire   +2 more sources

Post marketing surveillance for implants

International Journal of Risk and Safety in Medicine, 1996
openaire   +3 more sources

Post-marketing safety surveillance of erenumab: new insight from Eudravigilance

Expert Opinion on Drug Safety, 2022
David Liang, Maurizio Sessa
exaly  

Intussusception following rotavirus vaccine administration: Post-marketing surveillance in the National Immunization Program in Australia

Vaccine, 2011
Peter Mcintyre, Robert Booy, John B Carlin   +2 more
exaly  

Post market surveillance

2020
openaire   +1 more source

Safety and effectiveness of istradefylline in patients with Parkinson’s disease: interim analysis of a post-marketing surveillance study in Japan

Expert Opinion on Pharmacotherapy, 2018
Akihisa Mori, Makio Takahashi
exaly  

Safety and effectiveness of empagliflozin in Japanese patients with type 2 diabetes: interim analysis from a post-marketing surveillance study

Expert Opinion on Drug Safety, 2020
Yusuke Naito, Kohei Kaku, Atsutaka Yasui   +2 more
exaly  

Post‐marketing surveillance of novel foods

Pediatric Allergy and Immunology, 2002
openaire   +2 more sources

The safety and effectiveness of vonoprazan-basedHelicobacter pylorieradication therapy; a prospective post-marketing surveillance

Expert Opinion on Drug Safety, 2019
Shigeru Sakamoto
exaly